Investigators evaluated the occurrence of multiple sclerosis and neuromyelitis optica spectrum disorder in Australian and New Zealand Indigenous populations, comparing data with ancestral data.
A new study evaluated the prevalence of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) in Indigenous populations in Australia and New Zealand, with the Māori indigenous population in New Zealand showing higher prevalence of NMOSD. MS, conversely, was intermediate between those living in New Zealand with Southeast Asian and European ancestry, and both NMOSD and MS appeared to be uncommon in the indigenous populations of Australia.
Click HERE to Subscribe for the MS Beacon eNewsletter